Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Drug composition containing cefazolin and beta-lactamase inhibitor

A technology of lactamase and cefazolin, which is applied in the direction of medical preparations containing active ingredients, active ingredients of heterocyclic compounds, antibacterial drugs, etc., to achieve the effect of solving the problem of drug resistance, enhancing activity, and expanding the scope of antibacterial

Inactive Publication Date: 2003-06-18
YOUCARE PHARMA GROUP +1
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But so far, no one has studied cefazolin in combination with clavulanic acid or tazobactam

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Example 1: Mix 250 mg of cefazolin and 250 mg of clavulanic acid thoroughly, and operate according to the powder injection preparation process procedure.

Embodiment 2

[0044] Example 2: Mix 250 mg of cefazolin and 125 mg of clavulanic acid thoroughly, and operate according to the powder injection preparation process procedure.

Embodiment 3

[0045] Example 3: Mix 250 mg of cefazolin and 62.5 mg of clavulanic acid thoroughly, and operate according to the powder injection preparation process procedure.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An antibacterial composite medicine contains ancef or its salt and beta-lactamase inhibitor (tazobactam or clavulanic acid) in Wt ratio of (1-20):(1-5). Its advnatage is high synergistic antibacterial action.

Description

field of invention [0001] The present invention relates to a synergistic antibacterial pharmaceutical composition. Specifically, the pharmaceutical composition contains cefazolin and a β-lactamase inhibitor (tazobactam, clavulanic acid or a pharmaceutically acceptable salt thereof). It also relates to a method for preparing the pharmaceutical composition and the use of cefazolin and a β-lactamase inhibitor in the preparation of medicines for treating infectious diseases. Background of the invention [0002] Cefazolin is a known β-lactam antibiotic. The pharmacokinetic properties of this product are superior: high plasma protein binding rate, low distribution volume, and slow excretion rate, so the serum concentration is high and long-lasting. The treatment of diseases is often better than other first-generation cephalosporins, so it is widely used clinically. However, some data suggest that due to the instability of cefazolin to β-lactamase, some strains of Staphylococcus ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/43A61K31/546A61P31/04
Inventor 金描真白云
Owner YOUCARE PHARMA GROUP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com